Legal entity
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Dr. Garima Sharma, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.8 for the same window.
Last mentioned: Aug 1, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Dr. Garima Sharma, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.8 for the same window. The 6 average consequence score is above the beat benchmark of 5.8 in the same window. Dr. Anshu Bharadwaj appears in 1 tracked Legal story from August 1, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 28 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dr. Anshu Bharadwaj. Shared-story counts are live from our verified record — not editorial picks.
Stakeholder Consultation on SHANTI Act 2025 Implementation
NITI Aayog convened a high-level consultation in New Delhi to deliberate on the operational framework of the SHANTI Act 2025, focusing on regulatory, financial, and manufacturing pillars.
Legal experts will need to navigate complex new rules for nuclear FDI, liability, and insurance under the SHANTI Act. The consultation's three pillars provide a roadmap for compliance and corporate advisory.
Dr. Anshu Bharadwaj is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
